[Cryopreserved substance, isolated from human fetal liver, restore biochemical processes in acute liver failure].
Recovery processes dynamics in liver when treating experimental acute hepatic insufficiency (AHI) of various etiology by using cryopreserved biopreparations, obtained from human embryo liver of different terms of development (10-12 weeks), human fetuses (22-24 week of development).